Concepedia

Author

Eva Thijssen

Centre for Human Drug ResearchORCID

Also Known As

E Thijssen, E. Thijssen, Eva Thijssen

20

Publications

633

Citations

9

H-Index

18

Concepts

All Affiliations

Centre for Human Drug ResearchLeiden University Medical CenterRadboud University NijmegenRadboud University Medical CenterAlexza Pharmaceuticals (United States)
ET

About

Eva Thijssen is an author at Centre for Human Drug Research specializing in medicine, orthopaedics, and osteoarthritis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

132

2

Orthopaedics

2

2

121

3

Health Sciences

1

1

80

4

Cell Biology

1

1

41

5

Pharmacology

1

1

11

Eva Thijssen

×

8

Publications

266

Citations

8

H-Index

YearCitations

TGF-β is a potent inducer of Nerve Growth Factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain?

E.N. Blaney Davidson, A. van Caam, E.L. Vitters,

Osteoarthritis and Cartilage

2014

80

A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine

Hui Jing Yu, Eva Thijssen, Emilie M.J. van Brummelen,

Movement Disorders

2022

46

A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator

Jonas M. den Heijer, Annelieke C. Kruithof, Guido van Amerongen,

British Journal of Clinical Pharmacology

2021

44

Expression of TGFβ-family signalling components in ageing cartilage: age-related loss of TGFβ and BMP receptors

A. van Caam, Wojciech Madej, Eva Thijssen,

Osteoarthritis and Cartilage

2016

41

A Randomized Trial Assessing the Safety, Pharmacokinetics, and Efficacy During Morning <scp><i>Off</i></scp> of <scp>AZ</scp>‐009

Eva Thijssen, Jonas M. den Heijer, David Puibert,

Movement Disorders

2022

19

Treatment Detection and Movement Disorder Society‐Unified Parkinson's Disease Rating Scale, Part III Estimation Using Finger Tapping Tasks

Ahnjili Zhuparris, Eva Thijssen, Willem O Elzinga,

Movement Disorders

2023

13

A <scp>leucine‐rich</scp> repeat kinase 2 (<scp>LRRK2</scp>) pathway biomarker characterization study in patients with Parkinson's disease with and without <scp>LRRK2</scp> mutations and healthy controls

Maurits F. J. M. Vissers, Matthew D. Troyer, Eva Thijssen,

Clinical and Translational Science

2023

12

Safety and pharmacokinetics of multiple dosing with inhalable apomorphine (AZ-009), and its efficacy in a randomized crossover study in Parkinson's disease patients

Eva Thijssen, Jonas M. den Heijer, David Puibert,

Parkinsonism & Related Disorders

2022

11

Page 1